Advanced Filter

Filter by Group

Filter by Market Availability

Filter by Biologic Group

Displaying drugs 226 - 250 of 408 in total
Name Weight StructureDesriptionCategories
Pancrelipase lipase48000.0

A lipase used to treat pancreatic exocrine insufficiency.Carboxylic Ester Hydrolases / Lipase
Ranibizumab48349.6111

C2158H3282N562O681S12
A recombinant humanized monoclonal antibody and VEGF-A antagonist used for the management of macular edema after retinal vein occlusion, age-related macular degeneration (wet), and diabetic macular edema.Antineovascularisation Agents
Etanercept51234.9

C2224H3475N621O698S36
A protein therapy based on the binding fragment of the tumour necrosis factor alpha receptor used to treat severe rheumatoid arthritis and moderate to severe plaque psoriasis.Tumor necrosis factor alpha (TNF-alpha) inhibitors
Alefacept51801.1

C2306H3594N610O694S26
A recombinant fusion protein that binds CD2 and is used treat moderate to severe plaque psoriasis.Selective Immunosuppressants
Hyaluronidase (ovine)53870.9

C2455H3775N617O704S21
A purified form of sheep hyaluronidase enzyme used as an adjunct in subcutaneous rehydration therapy and to increase absorption of other drugs and radiopaque imaging agents.Enzymes
Efgartigimod alfa54000.0

A neonatal Fc receptor blocker used to treat generalized myasthenia gravis in patients who are AChR-antibody positive.Selective Immunosuppressants
Blinatumomab54100.0

C2367H3577N649O772S19
An antineoplastic antibody used to treat CD19-positive B-cell precursor acute lymphoblastic leukemia (ALL) in relapsed and refractory patients, as well as those in first or second complete remission with minimal residual disease (MRD).Antibodies, Monoclonal
Drotrecogin alfa55000.0

C1786H2779N509O519S29
A form of recombinant activated human protein C used to reduce mortality in patients with severe sepsis by inhibiting coagulation Factors V and VIII.Enzymes
Sebelipase alfa55000.0

C1968H2945N507O551S15
A recombinant lysosomal acid lipase used to treat lysosomal acid lipase deficiency.Cholesterol Ester Storage Disease, drug therapy / Enzymes / Hydrolytic Lysosomal Cholesteryl Ester-specific Enzyme / Hydrolytic Lysosomal Triacylglycerol-specific Enzyme / Wolman Disease, drug therapy
Alglucerase55597.4

C2532H3854N672O711S16
A form of recombinant beta-glucocerebrosidase enzyme used to replace the deficient endogenous enzyme in the treatment of Gaucher disease.Enzymes
Imiglucerase55597.4

C2532H3854N672O711S16
A form of recombinant human beta-glucocerebrosidase enzyme used to replace the deficient endogenous enzyme in the treatment of Gaucher disease.Enzyme Replacement Therapy / Enzymes / Gaucher Disease / Hydrolytic Lysosomal Glucocerebroside-specific Enzyme
Galsulfase56012.6

C2534H3851N691O719S16
A recombinant human enzyme used as replacement enzyme therapy for the treatment of of adults and children with Mucopolysaccharidosis VI, a rare genetic disorder caused by a deficiency of a lysosomal enzyme.Enzymes / Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme
Taliglucerase alfa56637.9397

C2580H3918N680O727S17
A hydrolytic lysosomal glucocerebroside specific enzyme, used for long term enzyme replacement therapy in patients with Type 1 Gaucher disease.Enzyme Replacement Therapy / Enzymes / Gaucher Disease / Hydrolytic Lysosomal Glucocerebroside-specific Enzyme
Pancrelipase amylase57086.0

A lipase used to treat pancreatic exocrine insufficiency.Amylases / Amylases, antagonists & inhibitors / Glycoside Hydrolases
Denileukin diftitox57647.3

C2560H4042N678O799S17
A recombinant cytotoxic protein based on a combination of diphtheria toxin fragments and interleukin-2 used to treat cutaneous T-cell lymphoma by targeting the interleukin-2 receptor.Antineoplastic Agents
Tagraxofusp57695.0

C2553 H4026 N692 O798 S16
A CD123-directed cytotoxin used to treat blastic plasmacytoid dendritic cell neoplasm.CD123 Interaction / Cytotoxins
Tenecteplase58951.2

C2561H3919N747O781S40
A modified form of recombinant human tissue plasminogen activator used in the emergency treatment of myocardial infarction and pulmonary emboli.Enzymes
Coagulation factor X human59000.0

A coagulation factor used to treat Factor X deficiency to control bleeding.Blood Coagulation Factors / Enzyme Precursors / Factor X / Factor X, agonists
Alteplase59000.0

C2569H3928N746O781S40
A recombinant form of human tissue plasminogen activator used in the emergency treatment of myocardial infarction, ischemic stroke, and pulmonary emboli.Enzymes
Romiplostim59000.0

C2634H4086N722O790S18
A fusion protein thrombopoietin (TPO) peptide analog that increases platelet counts by binding to and activating the human TPO receptor. Used to treat thrombocytopenia associated with chronic immune thrombocytopenia (ITP).Receptors, Thrombopoietin, agonists / Thrombopoietin Receptor Agonist
Anistreplase59042.3

C2569H3928N746O781S40
A form of recombinant human tissue plasminogen activator used in the emergency treatment of myocardial infarction and pulmonary emboli.Enzymes
Dulaglutide59669.81

C2646H4044N704O836S18
A GLP-1 agonist used to manage type 2 diabetes mellitus.Glucagon-like peptide-1 (GLP-1) analogues
Peginterferon alfa-2a60000.0

A modified form of recombinant human interferon used to stimulate the innate antiviral response in the treatment of hepatitis B and C viruses.Antiviral Agents / Drug Carriers / Interferon alpha / Interferons
Ropeginterferon alfa-2b60000.0

C16H29N3O6(C2H4O)n(C2H4O)n
A mono-pegylated type I interferon used to treat polycythemia vera.Interferons
Hyaluronidase (human recombinant)61000.0

An enzyme used to improve the absorption and dispersion of parenterally administered fluids, drugs, and contrast agents.Glycoside Hydrolases
Displaying drugs 226 - 250 of 408 in total